| Literature DB >> 31978123 |
Tine Alkjær1, Kenneth B Smale2, Teresa E Flaxman3, Ida F Marker1, Erik B Simonsen4, Daniel L Benoit2,3, Michael R Krogsgaard5.
Abstract
The forward lunge (FL) may be a promising movement to assess functional outcome after ACL reconstruction. Thus, we aimed to investigate the FL movement pattern before and after ACL reconstruction with a comparison to healthy controls to determine if differences were present. Twenty-eight ACL injured participants and 28 matched healthy controls were included. They performed FL movements while sagittal plane biomechanics of the knee and electromyography (EMG) of nine leg muscles was assessed. The ACL injured group was tested before and 10 months after surgery. The perceived knee function and activity level was assessed by questionnaires. The ACL injured group performed the FL significantly slower than the controls before surgery (mean difference: 0.41 s [95%CI: 0.04-0.79 s; p<0.05]) while they performed the FL as fast as the controls after surgery (~28% movement time reduction post-surgery). Perceived knee function and activity level improved significantly post-surgery. The knee joint flexion angle, extensor moment, power, angular velocity in the ACL injured group did not differ from pre to post-surgery. For the ACL injured group, the peak knee extensor moment observed both pre and post-surgery was significantly lower when compared to the controls. The EMG results showed minimal differences. In conclusion, at 10 months post-surgery, the FL was performed significantly faster and the movement time was comparable to that of the controls. While the perceived knee function and activity level improved post-surgery, the knee joint biomechanics were unchanged. This may reflect that knee joint function was not fully restored.Entities:
Mesh:
Year: 2020 PMID: 31978123 PMCID: PMC6980669 DOI: 10.1371/journal.pone.0228071
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Participant characteristics.
| Characteristic | ACLd (n = 28) | ACLr (n = 28) | Control (n = 28) | |||
|---|---|---|---|---|---|---|
| Sex (females/males) | 11/17 | 11/17 | 11/17 | |||
| Time since injury (months) | 19.7 | (29.6) | − | − | − | − |
| Time since surgery (months) | − | − | 10.7 | (1.7) | − | − |
| BMI (kg/m2) | 24.2 | (2.7) | 24.4 | (2.9) | 23.7 | (3.0) |
| Age (years) | 28.8 | (9.0) | 29.8 | (9.1) | 27.0 | (6.9) |
| Height (m) | 1.75 | (0.1) | 1.75 | (0.1) | 1.77 | (0.1) |
| Mass (kg) | 74.5 | (10.9) | 75.3 | (11.6) | 79.9 | (11.9) |
Values are mean (SD) for age, height, mass and sex are number of males and females.
Fig 1Individual and group mean FL movement time (s) of controls (n = 28, green dots), ACLd (n = 28, pre surgery, blue dots) and ACLr (n = 28, post-surgery, red dots). Group mean (black squares) with 95% CI. * indicates statistically significant difference between ACLd and controls. # indicates statistically significant difference between ACLd and ACLr (i.e. pre and post-surgery).
Forward lunge biomechanics.
| Mean ± SD | Mean difference (95% CI) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| ACLd (n = 28) | ACLr (n = 28) | Control (n = 28) | ACLd—ACLr | P value | ACLd—Control | P value | ACLr—Control | P value | |
| Vertical GRF (Fz) | 8.6 ± 0.6 | 9.0 ± 1.3 | 9.3 ± 1.5 | -0.4 (-0.9 to 0.2) | 0.192 | -0.7 (-1.3 to -0.05) | -0.3 (-1.1 to 0.4) | 0.414 | |
| Horizontal ant-post GRF (Fy1) | -2.5 ± 0.5 | -2.5 ± 0.4 | -2.6 ± 0.6 | 0.1 (-0.3 to 0.1) | 0.410 | 0.0 (-0.3 to 0.3) | 0.898 | 0.1 (-0.2 to 0.4) | 0.496 |
| Horizontal ant-post GRF (Fy2) | -3.0 ± 0.8 | -3.3 ± 0.8 | -3.5 ± 0.9 | 0.2 (-0.1 to 0.5) | 0.162 | 0.5 (0.0 to 0.9) | 0.3 (-0.2 to 0.7) | 0.264 | |
| 1–25% | -56.7 ± 9.2 | -53.8 ± 7.9 | -57.8 ± 10.1 | -2.6 (-6.5 to 1.4) | 0.188 | 1.0 (-4.2 to 6.3) | 0.692 | 4.0 (-1.0 to 8.9) | 0.056 |
| 75–100% | -64.2 ± 12.5 | -60.7 ± 8.6 | -64.8 ± 14.3 | -3.5 (-7.4 to 0.5) | 0.081 | 0.6 (-6.6 to 7.9) | 0.861 | 4.1 (-2.3 to 10.5) | 0.203 |
| Peak flexion | -105.3 ± 9.5 | -104.2 ± 9.7 | -109.2 ± 7.9 | -1.0 (-4.3 to 2.2) | 0.509 | 4.0 (-0.8 to 8.7) | 0.098 | 5.0 (0.2 to 9.7) | |
| Eccentric phase | -314.6 ± 96.6 | -332.6 ± 100.6 | -419.7 ± 128.5 | 15.7 (-5.0 to 36.4) | 0.131 | 105.2 (43.5 to 166.8) | 87.1 (24.5 to 149.7) | ||
| Concentric phase | 330.2 ± 87.8 | 358.2 ± 90.3 | 405.5 ± 115.0 | -21.9 (-53.2 to 9.3) | 0.160 | -75.3 (-130.8 to -19.8) | -47.4 (-103.4 to 8.7) | 0.096 | |
| 1–25% | 0.3 ± 0.2 | 0.2 ± 0.2 | 0.4 ± 0.2 | 0.03 (-0.04 to 0.1) | 0.333 | -0.2 (-0.3 to -0.05) | -0.2 (-0.3 to -0.1) | ||
| 75–100% | 0.3 ± 0.3 | 0.2 ± 0.2 | 0.4 ± 0.3 | 0.06 (-0.03 to 0.1) | 0.187 | -0.1 (-0.3 to 0.04) | 0.153 | -0.2 (-0.3 to -0.03) | |
| Peak moment | 0.7 ± 0.2 | 0.6 ± 0.2 | 0.8 ± 0.2 | 0.06 (-0.02 to 0.1) | 0.131 | -0.1 (-0.3 to -0.02) | -0.2 (-0.3 to -0.1) | ||
| Eccentric phase | -1.7 ± 0.8 | -1.7 ± 0.9 | -2.6 ± 1.7 | -0.0 (-0.4 to 0.4) | 0.993 | 0.9 (0.2 to 1.7) | 0.9 (0.2 to 1.7) | ||
| Concentric phase | 1.9 ± 1.3 | 1.6 ± 1.2 | 2.7 ± 1.6 | 0.3 (-0.1 to 0.7) | 0.185 | -0.7 (-1.5 to 0.1) | 0.068 | -1.0 (-1.8 to -0.3) | |
a Paired t-tests were applied to detect differences between variables between pre and post-surgery (ACLd—ACLr).
b Unpaired t-tests were applied to detect differences between variables between controls and pre surgery (ACLd—Control) and post-surgery (ACLr—Control).
Forward lunge muscle activities (%maxemg).
| Mean ± SD | Mean difference (95% CI) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| ACLd (n = 28) | ACLr (n = 28) | Control (n = 28) | ACLd—ACLr | P value | ACLd—Control | P value | ACLr—Control | P value | |
| Mean amplitude (% maxemg) | 9.7 ± 6.4 | 9.6 ± 6.0 | 7.8 ± 4.9 | 0.1 (-2.7 to 2.9) | 0.921 | 1.9 (-1.3 to 5.2) | 0.243 | 1.8 (-1.4 to 4.9) | 0.260 |
| Peak amplitude (% maxemg) | 25.0 ± 16.1 | 24.1 ± 12.4 | 18.7 ± 10.6 | 0.9 (-4.9 to 6.6) | 0.749 | 6.3 (-1.5 to 14.0) | 0.110 | 5.4 (-1.3 to12.0) | 0.110 |
| Mean amplitude (% maxemg) | 14.5 ± 9.3 | 13.3 ± 6.5 | 14.9 ± 11.0 | 1.2 (-2.8 to 5.1) | 0.551 | -0.4 (-6.2 to 5.3) | 0.877 | -1.6 (-6.8 to 3.6) | 0.537 |
| Peak amplitude (% maxemg) | 32.5 ± 20.9 | 33.6 ± 15.1 | 35.5 ± 24.1 | -1.0 (-11.4 to 9.4) | 0.840 | -2.9 (-15.7 to 9.9) | 0.648 | -1.9 (-13.4 to 9.6) | 0.741 |
| Mean amplitude (% maxemg) | 25.6 ± 17.1 | 23.2 ± 11.3 | 24.3 ± 13.6 | 2.4 (-3.3 to 8.0) | 0.395 | 1.3 (-7.4 to 10.0) | 0.764 | -1.1 (-8.1 to 6.0) | 0.763 |
| Peak amplitude (% maxemg) | 62.2 ± 34.6 | 59.7 ± 24.0 | 54.4 ± 26.6 | 2.4 (-9.4 to 14.2) | 0.676 | 7.7 (-9.6 to 25.0) | 0.373 | 5.3 (-9.0 to 19.6) | 0.458 |
| Mean amplitude (% maxemg) | 26.1 ± 17.3 | 21.4 ± 9.8 | 26.1 ± 12.7 | 4.7 (-1.4 to 10.8) | 0.125 | -0.1 (-8.6 to 8.5) | 0.990 | -4.7 (-11.2 to 1.8) | 0.149 |
| Peak amplitude (% maxemg) | 62.1 ± 30.9 | 58.0 ± 24.9 | 59.0 ± 25.7 | 4.1 (-8.3 to 16.5) | 0.500 | 3.1 (-13.1 to 19.2) | 0.705 | -1.0 (-15.3 to 13.3) | 0.882 |
| Mean amplitude (% maxemg) | 6.7 ± 4.7 | 6.4 ± 3.4 | 5.6 ± 3.4 | 0.3 (-1.4 to 1.9) | 0.731 | 1.1 (-1.2 to 3.4) | 0.333 | -0.8 (-1.1 to 2.8) | 0.381 |
| Peak amplitude (% maxemg) | 19.1 ± 13.1 | 18.9 ± 11.5 | 14.9 ± 9.0 | 2.1 (-4.0 to 4.5) | 0.920 | 4.2 (-2.1 to 10.5) | 0.186 | 4.0 (-1.8 to 9.8) | 0.174 |
| Mean amplitude (% maxemg) | 9.6 ± 8.3 | 10.1 ± 7.9 | 8.3 ± 6.4 | -0.5 (-4.1 to 3.1) | 0.783 | 1.3 (-2.9 to 5.5) | 0.537 | 1.8 (-2.3 to 5.8) | 0.382 |
| Peak amplitude (% maxemg) | 27.9 ± 22.6 | 25.5 ± 14.9 | 20.7 ± 13.1 | 2.4 (-6.5 to 11.3) | 0.580 | 7.2 (3.1 to 17.5) | 0.165 | 4.8 (-3.2 to 12.8) | 0.231 |
| Mean amplitude (% maxemg) | 17.2 ± 9.8 | 13.6 ± 5.5 | 15.5 ± 8.2 | 3.6 (-0.7 to 7.8) | 0.096 | 1.7 (-3.5 to 6.9) | 0.514 | -1.8 (-6.0 to 2.3) | 0.379 |
| Peak amplitude (% maxemg) | 46.6 ± 21.4 | 41.0 ± 17.5 | 39.2 ± 21.7 | 5.6 (-6.5 to 17.7) | 0.349 | 7.4 (-5.1 to 19.8) | 0.240 | 1.8 (-9.7 to 13.3) | 0.758 |
| Mean amplitude (% maxemg) | 15.4 ± 11.3 | 12.1 ± 7.4 | 9.6 ± 6.6 | 3.3 (-1.7 to 8.2) | 0.183 | 5.4 (0.3 to 10.5) | 2.1 (-1.8 to 6.0) | 0.281 | |
| Peak amplitude (% maxemg) | 52.5 ± 36.8 | 40.9 ± 23.7 | 36.8 ± 21.4 | 11.6 (-5.2 to 28.5) | 0.167 | 15.7 (-0.9 to 32.4) | 0.063 | 4.1 (-8.5 to 16.7) | 0.516 |
| Mean amplitude (% maxemg) | 11.3 ± 8.5 | 9.9 ± 8.6 | 11.7 ± 7.7 | 1.4 (-3.4 to 6.2) | 0.551 | -0.4 (-5.0 to 4.1) | 0.852 | -1.8 (-6.4 to 2.7) | 0.422 |
| Peak amplitude (% maxemg) | 30.4 ± 18.4 | 25.1 ± 18.6 | 28.2 ± 20.4 | 5.4 (-5.2 to 15.9) | 0.306 | 2.2 (-8.6 to 13.0) | 0.684 | -3.4 (-14.0 to 7.8) | 0.565 |
| Mean amplitude (% maxemg) | 18.9 ± 9.6 | 17.3 ± 7.1 | 11.3 ± 8.3 | 1.6 (-2.8 to 5.9) | 0.460 | 7.6 (1.8 to 13.4) | 6.1 (0.9 to 11.2) | ||
| Peak amplitude (% maxemg) | 44.3 ± 22.2 | 37.5 ± 13.2 | 28.4 ± 17.9 | 7.2 (-2.5 to 16.9) | 0.133 | 16.2 (3.2 to 29.3) | 9.0 (-1.7 to 19.7) | 0.095 | |
a Paired t-tests were applied to detect differences between variables between pre and post-surgery (ACLd—ACLr).
b Unpaired t-tests were applied to detect differences between variables between controls and pre surgery (ACLd—Control) and post-surgery (ACLr—Control).
c Missing EMG data: TFL: ACLd & ACLr (n = 6), CON (n = 1); RF: ACLd & ACLr (n = 4), CON (n = 1); VL: ACLd & ACLr (n = 3), CON (n = 2); VM: ACLd & ACLr (n = 4), CON (n = 2); BF & ST: ACLd & ACLr (n = 5), CON (n = 1); GL: ACLd & ACLr (n = 6), CON (n = 1); GM: ACLd & ACLr (n = 3), CON (n = 1); ADDUC: ACLd & ACLr (n = 3), CON (n = 1); GMED: ACLd & ACLr (n = 12), CON (n = 5).
Patient reported outcome measures and level of activity pre (ACLd) and post-surgery (ACLr).
| Mean ± SD | Mean difference (95% CI) | ||||
|---|---|---|---|---|---|
| ACLd (n = 28) | ACLr (n = 28) | ACLd—ACLr | P value | ||
| Lysholm score | 73.4 ± 11.2 | 84.3 ± 11.5 | -11.0 | (-16.5 to -5.5) | |
| IKDC | 71.0 ± 10.0 | 81.9 ± 9.6 | -10.7 | (-14.5 to -6.9) | |
| KNEES-ACL activities of daily living | 6.6 ± 4.5 | 3.8 ± 3.1 | 2.8 | (1.2 to 4.4) | |
| KNEES-ACL psychosocial | 5.7 ± 3.9 | 3.4 ± 3.6 | 2.2 | (0.8 to 3.6) | |
| KNEES-ACL symptoms | 4.8 ± 3.6 | 3.3 ± 3.5 | 1.4 | (-0.2 to 2.3) | 0.075 |
| KNEES-ACL slackness | 7.8 ± 3.3 | 5.0 ± 4.8 | 2.9 | (0.8 to 5.1) | |
| KNEES-ACL looseness | 4.4 ± 2.4 | 2.4 ± 2.4 | 2.2 | (0.8 to 3.5) | |
| KNEES-ACL sports behaviour | 13.1 ± 4.1 | 8.7 ± 5.3 | 4.0 | (2.3 to 6.6) | |
| KNEES-ACL sports physical | 3.8 ± 3.8 | 2.9 ± 3.1 | 0.9 | (-0.8 to 2.5) | 0.308 |
| KOOS symptoms | 81.3 ± 12.2 | 82.1 ± 12.1 | -0.4 | (-6.9 to 6.1) | 0.907 |
| KOOS pain | 82.4 ± 14.3 | 87.6 ± 10.8 | -5.0 | (-10.3 to 0.3) | 0.064 |
| KOOS activities of daily living b | 91.0 ± 9.7 | 91.8 ± 10.5 | -1.0 | (-4.1 to 2.1) | 0.516 |
| KOOS sports/recreation | 57.6 ± 24.2 | 70.8 ± 24.9 | -13.4 | (-24.6 to -2.2) | |
| KOOS quality of life | 41.7 ± 12.1 | 58.9 ± 16.5 | -18.0 | (-26.0 to -10.0) | |
| Tegner | 4.2 ± 1.2 | 5.5± 1.4 | -1.3 | (-2.0 to -0.7) | |
a Paired t-tests were applied to detect differences between variables between pre and post-surgery (ACLd—ACLr).
b Score range from 0–100 where higher scores represent higher levels of knee function.
c The individual subscales ranges of KNEES-ACL are: activity of daily living 0–24; psychosocial 0–15; symptoms 0–18; slackness 0–21; looseness 0–12; sports behaviour 0–18; sports physical 0–12 where higher values represent lower levels of knee function.
d Score range from 0–10 where higher levels represent higher activity level.